|Students Will Learn|
For Undergraduates and College Faculty
For Graduate Students
For High School Students and Teachers
There is no cost to attend the Programs for Students and registration for the Annual Meeting is not required; however, preregistration is requested. Contact ASCB for information about the High School and College Programs Phone: (301) 530-7153; Fax: (301) 530-7139. Graduate students may indicate their intention to attend the Graduate Student Presentation on the Annual Meeting Advance Registration/Payment Form in the 37th ASCB Annual Meeting Call for Abstracts.
|Call for Educational Initiatives Forum Speakers|
For five years, the ASCB Education Committee has hosted the Educational Initiatives Forum during the breaks separating morning Symposia at the Annual Meeting. Typically, the speaker or panelists for each session present 15-20 minutes of remarks on various subjects related to educational initiatives in cell biology, and the remainder of the session is devoted to discussion. The Forum encourages presentations of innovative solutions to educational and related professional problems and discussion of problems and solutions. It is an ideal venue for networking with other individuals with similar interests. The 1996 Forum in San Francisco included presentations by William Heidcamp on "Teaching Materials Available via the Internet," Celia Jamur on "Teaching Cell Biology with Limited Resources," Malcolm Campbell on "Inovative Teaching Methods," Lawrence Jensen on "Computer-Generated Models as Teaching Aids," and Nancy Lane on "Methods to Interest Students Belonging to Under-represented Groups." Any member wishing to make a presentation at one of the Educational Initiatives Forum sessions should contact the ASCB Office or the Forum's convener, ASCB Education Committee member Chris Watters, at (802) 443-5433. Better still, email Chris a brief summary or outline of the proposed presentation.37th ASCB Annual Meeting News
Sunday, December 14
Tom Jessell, Columbia University College of Physicians & Surgeons
Marc Tessier-Lavigne, University of California, San Francisco
Protein Misfolding & Degradation: Cellular Control and Viral Escapes
Aaron Ciechanover, Technion Israel Institute of Technology
Peter Walter, University of California, San Francisco
Monday, December 15
Jennifer Lippincott-Schwartz, NIH, NICHD
Graham Warren, Imperial Cancer Research Fund
The Role of ECM and Integrins in Regulating Higher Order Structure and Gene Expression
Arthur Lander, University of California, Irvine
Kenneth Yamada, NIH, NIDR
Tuesday, December 16
John Cooper, Washington University
Pascale Cossart, Institut Pasteur
Nuclear Dynamics and Function
Bruce Stillman, Cold Spring Harbor Laboratory
Shirley Tilghman, Princeton University
Wednesday, December 17
Dan Littman, Skirball Institute, HHMI, New York University Medical Center
Robin Weiss, Institute of Cancer Research, Royal Cancer Hospital (UK)
Judith Kimble, University of Wisconsin
Mark Krasnow, Stanford University
Aging and Senescence
Eugenia Wang, Lady Davis Institute, Montreal
Apoptosis and Cellular Control
Vishva Dixit, University of Michigan Medical School
CDKs and CKIs in Cellular Growth, Mitosis and Disease
Charles Sherr, HHMI, St. Jude Children's Research Hospital
Cell Adhesion and Homing
Denisa Wagner, Harvard Medical School
The Cell Biology of Neurodegenerative Disease
Sangram Sisodia, Johns Hopkins University School of Medicine
Cell-Cell Adhesion & Junctions
Barry Gumbiner, Memorial Sloan-Kettering Cancer Center
Chromatin: Assembly, Remodeling, Histone Modification
Lorraine Pillus, University of Colorado
D.J. Pan, University of California, Berkeley
Left-Right Asymmetry: From Molecules to Clinic
William Wood, University of Colorado
Lipid Regulators of Cell Function
Scott Emr, University of California, San Diego
Maternal Regulation of Embryonic Polarity
Gertrud Schupbach, Princeton University
Mechanisms of Cell Motility and Cytokinesis
Yu-li Wang, Worcester Foundation for Biomedical Research
Membrane Trafficking: New Paradigms and Directions
Kathryn Howell, University of Colorado
Conly Rieder, Wadsworth Center Laboratories
The Molecular Basis of Sensation
Robert Margolskee, Mt. Sinai School of Medicine
Nuclear Entry and Exit: The Rules and Players
Susan Wente, Washington University
Organelle Integrity and Inheritance
Michael Yaffe, University of California, San Diego
Jorge Galan, State University of New York at Stony Brook
Joan Ruderman, Harvard Medical School
Regulating the Polymers of the Cytoskeleton
Yixian Zheng , Carnegie Institution of Washington
RNA: Untranslated Sequences Controlling Localization, Stability and Differentiation
Robert H. Singer, Albert Einstein College of Medicine
Signal Transduction in Normal and Malignant Cells
Ann Richmond, Vanderbilt University
Structure and Function of Kinetochores
Gary Gorbsky, University of Virginia Health Sciences Center
Transport Across the Membrane Bilayer
Tom Rapoport, Harvard Medical School
Congressional Research Service Summer Openings
Postdoctoral positions available immediately in the Northwestern Drug Discovery Program (DDP). The DDP is an academic basic science program that focuses on normal and pathological cell regulatory mechanisms as starting points in the discovery of potential new drug targets. These investigations are interdigitated with structural biology and medicinal chemistry studies that develop new lead chemical entities. Successful applicants will have a Ph.D., M.D. or equivalent and documented record of productivity. Individuals are expected to develop a customized research program with a DDP sponsor. Although highly competitive applicants in any relevant area may apply, there is a current special need for individuals with expertise in molecular biology and genetics, and molecular or clinical neurosciences. Submit a current C.V., names and addresses of three references, and a statement of research interests to D.M. Watterson, DDP, P.O. Box 118126, Chicago IL 60611. EOE/AA.
Postdoctoral positions are available 07/01/97 for training in Environmental Mutagenesis and Carcinogenesis in a program supported by an Institutional National Research Service Award from NIEHS. There are 12 faculty members. Applicants must have MD/PhD, experience in genetics, cell, or molecular biology, and be a US citizen or permanent resident. To apply, send resume, transcripts and three letters of reference to: Dr. Zena Werb, Program Director, Department of Anatomy, Box 0750, University of California, San Francisco, CA 94143-0750. EOE/AA.
Postdoctoral position in cellular and molecular neurobiology: Studies include: analysis of factors controlling transcription of adhesion molecule genes in vivo and in vitro, identification of signal pathways and the gene programs activated by adhesion molecule binding. Contact: Gerald M. Edelman, Department of Neurobiology, Scripps Research Institute, 10550 North Torrey Pines Rd., SBR14, La Jolla CA 92037. EOE/AA.
PhD in Pharmacology or related areas, 4-8 years experience in research/industry needed to develop in vivo models for drug evaluation for age-related diseases including cancer and to manage the animal facility. Expertise with animal models and pharmacological methods required. Experience with toxicology and pharmacokinetics, and AALAS Certification desirable. CV to: Geron Corp. Human Resources, 230 Constitution Dr., Menlo Park CA 94025. EOE/AA.
Postdoctoral positions are available to study neuropeptide receptor functions. Approaches include binding, second messenger signaling, cloning, antibodies, etc. Candidates with a background in neurochemistry/molecular biology should send cv, three letters of recommendation to: Dr. N. M. Lee, CPMC Research Institute, 2330 Clay Street, San Francisco, CA 94115-1932. Fax: (415) 561-1390. EOE/AA.
Postdoc/Res Assoc, PhD; avail immed to study synthesis, processing & trafficking of cartilage extracellular matrix molecules, emphasiz aggrecan, models of chondrodysplasias. Expertise in molec biol &/or light/electron microsc immunolocalizat required. Contact Barbara Vertel, Dept Cell Bio & Anat, FUHS/The Chicago Med School, 3333 Green Bay Rd, No. Chicago, IL 60064. Fax: (847) 578-3272. EOE/AA.
Faculty positions: Assistant or Associate Professor. Teaching participation required in team-taught courses. Active and vigorous research program in Cell Biology required. Expected to start July, 1997. Send letter of interest, cv, and names of referees to: Dr. David McCandless, Department of Cell Biology and Anatomy, Finch University of Health Sciences/The Chicago Medical School, 3333 Green Bay Road, North Chicago IL 60064. EOE/AA.
Product Manager, imaging and cytometry products. Coordinate all imaging and cytometry-related marketing activities. Requires: 3 years postdoc exper. in cell biology, neuroscience, histochemistry, immunology; extensive lab exper. in fluorescence microscopy; excellent communication skills; publications in the field. See more detailed description under the heading "What's New?" EOE/AA.
Postdoc Fellowships: NIEHS Training Program, recent PhD, MD, DVM; Available immed/future.US citizen/perm. resident. Molecular and cell biology of carcinogenesis; transformation of human or rodent cells; DNA damage, repair, mutation; cell cycle regulation; oncogenes, growth factors; gene and chromosome transfer. Contact Dr. D. G. Kaufman, Dept. Path. & Lab. Medicine, U. North Carolina, Chapel Hill NC 27599-7525. (919) 966-1396, Fax: (919) 966-5046. EOE/AA.
Postdoc to study cytoplasmic organelle partitioning during cell division. Vacuole inheritance in yeast is being investigated through genetic, molecular and cellular techniques. Recent publications include Hill et al., JCB 135:1535 (1996), Wang et al. MBC 7:1375 (1996). Contact: Lois Weisman, Department of Biochemistry, University of Iowa, Iowa City IA 52242. (319) 335-8581.. EOE/AA.
Postdoctoral position available immediately to investigate survival signals for retinal photoreceptors, and their potential involvement in blinding retinal degenerations. The program involves cell culture, multiple cloning strategies, biochemistry, in situ hybridization and immunocytochemistry. Contact: Ruben Adler, Johns Hopkins Univ Sch Med; (410) 955-7589; EOE/AA.
Postdoctoral Position. Lung Biology Center, University of California San Francisco, to investigate integrin-mediated signaling and interaction with oxidant- and asbestos-induced apoptosis. Recommend experience in signaling, molecular and cellular biology. Available July, 1997 or later. Contact Dr. C. Broaddus, Box 0854, UCSF, San Francisco CA 94143-0854. (415) 206-3513. EOE/AA.
Research laboratory near Nice, France (Marine Station of Villefranche-sur-mer) looking for a Post-doc interested in differentiation of muscle cells and myogenic factors in embryos. Experience in molecular biology required. Position available immediately; 10,000 FF per month for one year; extension possible. Contact Christian Sardet or Janet Chenevert Phone: 493763771, Fax: 493763792, EOE/AA.
Postdoctoral Fellow to study mechanisms used by fibroblasts and tumor cells to invade extracellular matrix. Living cells will be studied by Confocal Microscopy. The project involves bleaching and activating flourescent probes. Both cellular and molecular techniques will be applicable. Reply to: Dr. E.D. Hay; EOE/AA.
Graduate Teaching Fellowships available fall, 1998, to support PhD candidates. Fellowship may be renewable for up to 5 years. Contact N. Gotelli, Department of Biology, University of Vermont, Burlington VT 05405. EOE/AA.
Postdoctoral Fellow to study peroxisomal assembly. Issues are protein and lipid trafficking, membrane translocation, and organelle division and segregation. Expertise in one or more of the following areas will be useful: yeast cell biology or genetics, molecular biology, and membrane biochemistry. Available immediately. Contact Joel Goodman, UT Southwestern Medical School, Dallas TX 75235-9041. EOE/AA.
Postdoctoral Researcher. PhD/MD/DVM. Cellular and molecular aspects of reproduction (gametogenesis, fertilization, endocrinology, implantation) or embryogenesis (preimplantation development, organogenesis). Start date and salary negotiable. Contact: Center for Research on Reproduction and Women's Health, Univ Pennsylvania Med Ctr, 778 CRB, 415 Curie Blvd, Philadelphia PA 19104-6142. Phone: (215) 898-0147; Fax: (215) 573-5408. EOE/AA.
Postdoctoral position available to investigate mechanisms by which MAP kinases modulate activity of AP-1 transcription factors. Strong molecular biology background required. Send cv with names and addresses of 3 references to: Lori Bernstein, PhD, Department of Pathology and Laboratory Medicine, Texas A & M, HSC 208 Reynolds Building, College Station TX 77843-1114 USA. EOE/AA.
Postdoctoral position available to study viral replication, polyprotein processing and morphogenesis of gastrointestinal viral pathogens. Experience in molecular biology and virology required. U.S. citizenship required. Start date flexible. Please send CV and names of three references to: Dr. S.M. Matsui, Division of Gastroenterology, MSLS P304, Stanford University School of Medicine, Stanford, CA 94305-5487. EOE/AA.
Postdoctoral fellow (less than 5 years experience) is sought with confocal microscopy training for studies of glucose transporter trafficking and regulation by insulin. A transient transfection system is also available to examine trafficking and regulatory proteins. Contact Dr. Sam Cushman, 10/5N102/NIH, 10 Center Dr. MSC 1420, Bethesda MD 20892-1420. EOE/AA.
Postdoctoral fellowship 1997-2000: To study the role of the ubiquitin system in growth hormone receptor downregulation, a cooperative project with Dr. Ciechanover, Haifa. Info: Dr. G. Strous, Dept. Cell Biol, Heidelbergl. 100, AZU H02.314; 3584CX Utrecht, tel +31 302506476; Funded for 2 years for EU nationals only. The Utrecht University is an EOE/AA.
Experienced scientists are sought to join a cadre of Scientific Review Administrators in building the future of the Division of Research Grants at NIH. If you possess a Ph.D.or M.D. degree (or equivalent), have completed postdoctoral training, and have a record of independent research accomplishments, please indicate your interest by sending a CV to:
Ellie Ehrenfeld, Director
Do You Need a Postdoc, a Research Associate or Fellow?
Look to the ASCB first to fill a vacancy by placing your recruitment advertisement in the monthly ASCB Newsletter.
Low Rates: $7.50/line, 10-line minimum
Contact: R. Sommer; Phone (301) 530-7153; Fax (301) 530-7139.
|Dudley Wright 1999 Conference Proposals Sought|
Letters to the Editor
Dear Ms. Marincola:
Following up with Mentors
ASCB/EMBO/H. Dudley Wright 1999 Conference Proposals Sought
ASCB members who wish to propose a conference topic should contact me using a written communication medium of your choice (please do not call with proposals, as I frequently lose notes taken on phone conversations). Electronic mail, Fax (603) 646-1347, and the US mail (Department of Biological Sciences, Dartmouth College, Hanover NH 03755) all seem to work well. A phone call (603-646-2377) is appropriate if members just wish to chat informally about possibilities or procedures, etc. Staff support is provided by Dorothy Doyle in the ASCB National Office; logistical inquiries may be directed to her at (301) 530-7153; Fax: (301) 530-7139.
The conference receives financial support form the ASCB, EMBO, and the H. Dudley Wright Foundation. Dudley Wright was a farsighted Swiss industrialist who initially supported these meetings with personal funds. On his death, the H. Dudley Wright Foundation agreed to continue his personal commitment through the 1990s.
The ASCB/EMBO/H. Dudley Wright conferences are held biennially to foster international collaboration and exchange of ideas on important and timely topics in cell biology. In choosing a topic, the respective committees of the ASCB and EMBO give strong preference to interdisciplinary topics of mutual interest to the membership of the two organizations. It is hoped that such an international focus will mean there is high probability of the conference exerting a significant impact on research in the topic area.
Please note that the Education Committee of the ASCB advises organizers to pay particular attention to the following points governing meetings: every effort possible should be made to maintain a balance between European and North American representation in the choice of speakers, session chairs, and meeting attendees. It is also expected that every effort will be made to maintain a balance between breadth of speaker and participant representation with respect to (i) laboratories and countries, (ii) established and young investigators, and (iii) postdocs and graduate students. Meeting organizers are also encouraged to try to ensure appropriate representation by women and minority group members.
If anyone wishes to make general comments concerning the ASCB/EMBO/H. Dudley Wright summer conferences, please contact the Education Committee of the ASCB (9650 Rockville Pike, Bethesda MD 20814-3992) or the Course Committee of EMBO (Postfach 10022.40, Meyerhoffstrasse 1, 6900 Heidelberg 1, Germany). Formal proposals for conference topics should include, but not be limited to, the following: the subject, with some statement as to the interdisciplinary nature and its importance to the international cell biology community, the name of a potential European co-organizer (or a North American co-organizer if the proposer is from Europe), a brief outline of session topics, and a brief list of potential speakers (commitment from whom is not required at the time the topic is proposed). Finally, individuals proposing conference topics must comment as to their willingness to participate in fund raising.
-Roger D. Sloboda, Department of Biological Sciences, Dartmouth College, Hanover, NH 03755; Fax: (603) 646-1347, for the ASCB Education Committee.
|Grants, Opportunities and Courses|
Penn State University is announcing new graduate programs in Integrative Biosciences.
Research Associateship awards: The National Research Council offers awards for postdoctoral scientific research to be conducted at participating US government research laboratories. Awardees design projects that are compatible with the overall interests of a sponsoring laboratory. Duration of awards is 1 year with renewals possible for 3 years maxmum. Annual stipends range from $30,000 to $45,500 depending upon sponsoring laboratory. Awards include support for relocation and professional travel. For information and application materials visit our web site or contact the Associateship Programs, NRC, TJ2114/CB, 2101 Constitution Ave., NW, Washington DC 20418; fax: (202) 334-2759; Qualified applicants will be reviewed without regard to race, creed, color, age, sex or national origin.
|Congressional Budget Process Still Stalled|
Congressional Budget Process Still Stalled
Over the last several weeks there have been many attempts to break the impasse. First, there was the call for a commission to adjust the Consumer Price Index (CPI), but President Clinton decided against it. Such a commission might have recommended a reduction in the CPI which would have limited increases in social support, in turn reducing the debt and easing the pressure to balance the budget by cutting discretionary programs. Without the commission, the CPI reduction idea is likely dead for the year. Next, House Speaker Newt Gingrich (R-GA) called upon his colleagues to postpone tax cuts until the budget is balanced. Presumably his hope was that without a tax cut on the table, Democrats would be less able to criticize the Republican budget plan and would, therefore, be forced to negotiate the budget. Speaker Gingrich was quickly discouraged by fellow Republicans, many feeling that he had betrayed their cause. The Speaker recanted, declaring that he would continue to push for a tax cut this year. Meanwhile, a group of moderate to conservative Democrats known as the "Blue Dogs" came out with their own balanced budget plan which also takes tax cuts off the table and which calls for an 0.8 percent cut in the CPI. While Representative John Kasich (R-OH), Chairman of the House Budget Committee, has promised that this plan will come up for a vote on the floor, it is likely to be defeated. There is some hope that this centrist plan might be a reasonable point of negotiation for the two parties. Nineteen members of the House Republican Mainstream Conservative Alliance have endorsed the Blue Dogs' effort. Senator Pete Domenici (R-NM), Chairman of the Senate Budget Committee, has filed a temporary budget proposal which he characterized as a "space holder" for the real budget to come later. This temporary budget does not include a tax cut but it does cut discretionary programs. Senator Domenici admits that he does not support this plan, but argues that it served to meet the April 1 deadline for a budget resolution in the Senate.
There has been a great deal of partisan rhetoric regarding the budget process, the Democrats complaining about the slow pace, and the Republicans complaining about the Administration's unwillingness to compromise. This division has contributed to the partisan debate about whether to use the budget projections from the Congressional Budget Office (CBO), which are consistent with the Republicans' projections, or those from the Office of Management and Budget (OMB) which are consistent with the Administration's projections. Ironically, the two sets of figures differ by only two-tenths of a percentage point. It has also been noted that both agencies drastically over-estimated the deficit last year, making this year's projections by both agencies questionable. Although the CBO and the OMB are not far apart, Chairman Kasich has said he will only use the CBO numbers, while OMB Director Franklin Raines insists that his projections are more accurate. Some have called for a compromise between the two figures, but so far there is no sign of one. This seemingly minor disagreement between the CBO and the OMB has added to the difficulty of moving the budget.
Following some of the efforts to accelerate the process, President Clinton invited Congressional budget leaders to the White House to discuss the budget. While the President expressed optimism following the meeting, Rep. Kasich called it "just talk." There have also been informal talks between staff on the Hill and in the Administration with little success so far. Both parties want to be seen as willing negotiators, but neither wants to make tough choices on the budget for fear of being blamed for the inevitable consequent unhappiness at next election. If no budget resolution is passed by May 15, the appropriations bills including those that fund biomedical research will move by default. Rep. Robert Livingston, (R-LA), Chairman of the House Appropriations Committee, declared that if a budget reconciliation bill is not produced by the deadline, FY97 spending levels will be used as the gauge for the Appropriations Committee. Following Easter recess, Rep. Livingston's Committee began discussion of a $8.4 billion defense-disaster supplemental funding bill. This bill would provide for the military effort in Bosnia and for disaster relief for victims of the floods in the Midwest. In order to pay for the proposed legislation, the Appropriations Committee would have to cut other programs. While they may not cut the NIH, this bill puts added pressure on the discretionary budget.
The House Labor, Health and Human Services and Education Appropriations Subcommittee (LHHS) continued its hearings through April. Congressman John Porter, Chairman of the Subcommittee, who recently announced he would not run for the U.S. Senate as some had thought he might, spoke hopefully about next year's NIH budget. On April 15, Jack Dixon of the ASBMB testified on behalf of the Joint Steering Committee for Public Policy before Rep. Porter's Subcommittee (see page 17). (The Senate LHHS committee did not hear public witnesses in appropriations hearings this year.) Senator Edward Kennedy (D-MA), ranking member of the Senate Labor and Human Resources Committee, was the first Democrat in the Senate to publicly endorse the doubling of federal support for medical research. Kennedy is not yet a cosponsor of S Res. 15 calling for the doubling of the NIH budget.
New NSF Merit Review Criteria
Since 1981, NSF study sections reviewed four criteria when considering a grant application:
The new criteria were reviewed by the Merit Review Task Force of the National Science Board and will be implemented over the next year.
Joint Steering Committee for Public Policy
Congressional Biomedical Research Caucus
Representative Barney Frank
District-based Extension of Congressional Liaison Committee Activities
Coordination with Physical Scientists
Dixon Testifies Before Appropriations Committee
"Good afternoon, Mr. Chairman and members of the Subcommittee. My name is Jack E. Dixon. I am Professor and Chair of the Department of Biological Chemistry at the University of Michigan Medical School and the President of the American Society for Biochemistry and Molecular Biology. I am here today representing the Joint Steering Committee for Public Policy, a coalition of five life science societies representing more than 20,000 researchers in the fields of anatomy, biochemistry and molecular biology, biophysics, cell biology, and genetics. My purpose today is to discuss with you and your colleagues the need for a generous appropriation for the National Institutes of Health (NIH), the world's premiere supporter of biomedical research.
I want to begin by thanking Congress, and you especially, Mr. Chairman, for the good support for NIH you have provided over the years. It has allowed thousands of researchers around the country to devote their lives and careers to unraveling some of the great biological mysteries that have confounded science for many decades. Your support of this work has led to profound advances in the treatment of disease, which has directly benefited every American.
Members of the Joint Steering Committee for Public Policy
I know that you share my belief that biomedical research is one of the best investments that the federal government can make with public funds. I am therefore mindful of the awesome responsibility you have placed with those of us who are the practitioners of biomedical research to spend public funds wisely, and exercise the highest standards of responsible stewardship. It is a privilege to be a biomedical researcher, and I appreciate very much your support and trust.
The Joint Steering Committee, as well as virtually all the rest of the life sciences community, is supporting an appropriation for NIH in fiscal 1998 of $13.894 billion, an increase of $1.14 billion, or 9 percent, over the fiscal 1997 figure of $12.747 billion. This is an ambitious recommendation, and is very justifiable on a variety of grounds. Let me first review for you some recent NIH-funded research advances, and talk a bit about their implications.
I myself have been privileged to receive NIH support since the early 1970s. I want to talk just a bit about my own work and how it impacts on human health. In the early 1980s, NIH-supported scientists demonstrated that receptors such as the insulin receptor were turned on by phosphorylation and turned off by dephosphorylation. We began to study the enzymes responsible for turning off the receptors. To our surprise, these enzymes not only regulated the insulin receptor, but also other receptors. Basic research findings are now providing the fundamental knowledge that pharmaceutical firms and the biotechnology industry are using to design drugs to effectively block the dephosphorylation of the insulin receptor and in turn treat diabetes. I feel that I have been very fortunate to have had the opportunity to study this family of dephosphorylating enzymes which have the potential for altering the course of human disease.
Mr. Chairman, the Congress' generous support for NIH in the past has brought us to the edge of a new age of discovery in biomedical research. This new age of discovery will make all that has come before—even the astonishing advances I have mentioned today—seem in retrospect to have been mere first steps toward a vastly more profound and unified understanding of the fundamental biological processes that cause many of our human frailties. This new understanding will bring about such a vast array of new treatments for disease, that today's medicine will someday be considered as primitive as bleeding and mercury ingestion seem today. The question is not "if" we will reach this new standard, it is "when". The United States Congress can in great part claim credit for the "when".
Our country is blessed with a research infrastructure filled with talented investigators. These researchers have devoted their lives to contributing to human understanding of the fundamental biological processes that will eventually lead to treatments for many of the scourges—cancer, heart disease, stroke, and diabetes—that have afflicted humanity for millennia, as well as finding cures for new scourges such as AIDS.
It is true and undeniable that this work costs money. Sadly, some may even think it costs too much money, and that we can't afford it. I believe that indeed we cannot afford not to do it. In fact, biomedical research is one of the most cost-effective ways to spend federal dollars, saving in the long run vastly more money than is spent initially. Even the most conservative estimates of the payoffs from biomedical research estimate a 28 percent return on our investment, when one factors in money saved from the availability of less expensive treatments, less time lost at work, fewer illnesses in the first place, and the contributions of the biotechnology and pharmaceutical industries to our gross domestic product and the balance of trade. For example, the biotechnology companies employ over 100,000 people, while the pharmaceutical industry is one of our most dynamic enterprises and a leading export industry.
Thus, when one considers all the benefits that have flowed, and will continue to flow, to our country from federally-funded biomedical research, a 9 percent increase in the NIH budget this year doesn't seem so aggressive after all. Some might even call it parsimonious!
Mr. Chairman, I want to close with one other point about what the NIH budget supports. In addition to support of research, the budget also supports training for new biomedical researchers, primarily through the National Research Service Awards program. This support for training is one of NIH's more unsung but vital functions. In addition, NIH's efforts to train the next generation of researchers cross all boundaries of gender, race, and ethnic background, since scientific talent knows no such restrictions. Yet funding of this essential function has remained flat for several years.
Mr. Chairman, this concludes my testimony. Thank you again for the opportunity to appear. It has been an honor and a privilege. I will be happy to answer any questions you may have."
|Attention Graduate Students|
Students who are interested in volunteering time (up to six hours) in exchange for free registration for the 37th ASCB Annual Meeting ($30 value for members; $60 value for nonmembers) and a free social ticket ($25 value in advance; $45 on-site), may complete this form and return it to the ASCB. Priority is given to students who are ASCB members or who have submitted a membership application. Postdocs may be offered this opportunity but precedence goes to students.
ASCB Student Member or Application Pending?: yes no
ASCB Postdoc Member or Application Pending?: yes no
Return form or direct inquiries to:
|WWW.Cell Biology Education|
The ASCB Education Committee calls attention each month to several Web sites of educational interest to the cell biology community. The Committee does not endorse nor guarantee the accuracy of the information at any of the listed sites. If you wish to comment on the selections or suggest future inclusions contact Bob Blystone
URLs 1-3 were checked January 31, 1997; URLs 4-6 were checked March 12, 1997.
Robert V. Blystone for the ASCB Education Committee
|Members In the News|
Shu Chien, ASCB Member since 1986, of the Department of Bioengineering at the University of California, San Diego School of Engineering, has been elected to the National Academy of Engineering (NAE). Chen is one of 95 engineers who were elected to the Academy. He was recognized for his research in atherogenisis, tissue engineering, blood rheology, microcirculation, and cell mechanics.
Robert O. Kelley, ASCB member since 1970, was named Chair-elect of the Association of American Medical Colleges (AAMC). Kelley is professor and chairman of the Department of Anatomy at the University of New Mexico; he will serve as AAMC Chair in 1997-98. Kelley will succeed as Chair Mitchell Rabkin, longtime President of Beth Israel Hospital in Boston, who is currently Chief Executive Officer of CareGroup, Inc.
Bob Weinberg of the Whithead Institute was awarded the National Medal of Science. Weinberg has been a member of the ASCB since 1993.
|Call for Nominations for WICB Career Recognition Awards|
The WICB Committee recognizes outstanding achievements by cell biologists through the presentation of the Career Recognition Awards at the Annual Meeting of the ASCB. Two awards are given each year. The Junior Award is given to a woman in an early stage of her career (i.e. assistant professor or equivalent) who has made significant scientific contributions to cell biology and exhibits the potential for continuing a high level of scientific endeavor while fostering the career development of young scientists. The Senior Award is given to a woman or man in a later career stage (i.e. full professor or equivalent) whose outstanding scientific achievements are coupled with a long-standing record of supporting women in science and mentoring both men and women in scientific careers.
In 1996, the Junior Award was presented to Susan Forsburg of the Salk Institute for Biological Sciences, and the Senior Award was presented to Sarah Elgin of Washington University.
To submit a nomination for a 1997 Career Recognition Award, send the nominee's curriculum vitae and a minimum of one letter of recommendation to Dorothy Doyle at the ASCB National Office, 9650 Rockville Pike, Bethesda, MD 20814 by August 1.